Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

CIFI HOLD GP (00884) Mandatory Convertible Bonds Converted Over $815 Million, Initial Regular Mandatory Conversion Not Triggered.

BG BLUE SKY (06828) received a notice of appeal in a litigation case.

SHOUCHENG (00697) invests in Huaxia Zhongke Clean Energy REIT and increases its stake in infrastructure assets.
CIFI HOLD GP (00884) Mandatory Convertible Bonds Converted Over $815 Million, Initial Regular Mandatory Conversion Not Triggered.

BG BLUE SKY (06828) received a notice of appeal in a litigation case.

SHOUCHENG (00697) invests in Huaxia Zhongke Clean Energy REIT and increases its stake in infrastructure assets.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


